CDSCO panel gives nod for continuation of phase-II clinical trial of SII’s dengue vaccine
New Delhi: An expert committee under the Central Drug Regulatory Authority has recommended continuation of phase II clinical trial of the Serum Institute Of India (SII)’s vaccine against dengue after…
SII Ships First Set Of R21/Matrix-M™ Malaria Vaccine To Africa
PUNE: Serum Institute of India, the world’s largest manufacturer of vaccines by number of doses, marks a significant milestone with the shipment of its first set of R21/Matrix-M™ malaria vaccine to…
Disclosed all rare to very rare side-effects of Covid vaccine ‘Covishield’ since ’21
PUNE: City-based Serum Institute of India (SII) on Wednesday said it had disclosed all rare to very rare side-effects of Covid-19 vaccine, supplied under the name Covishield, in the packaging insert in 2021…
Mansukh Mandaviya Packs a Punch in COVID Vaccination
New Delhi: Mansukh Mandaviya needed a Godspeed because he has been handed Health Ministry in testing times. The speeding up of vaccination drive underlines he is packing a punch. September…
Tata in talks to launch Moderna vaccine in India
Mumbai: Tata Medical & Diagnostics, a newly formed subsidiary of Tata Sons, is said to have started initial discussions with US company Moderna for a partnership to launch its Covid-19 vaccine in India.…
AstraZeneca-Oxford Vaccine Still Under Review: UK Drug Regulator
Mumbai/ New Delhi : The UK’s drug regulator, Medicines and Healthcare Products Regulatory Agency (MHRA) is still reviewing the AstraZeneca/ Oxford vaccine, which has implications for Serum Institute of India’s (SII)…
Rotasiil –Liquid, new Rotavirus Vaccine, launched to boost fight against Diarrhoea
New Delhi: In a bid to strengthen routine immunization and tackle the menace of Diarrhoea, Serum Institute of India (SII), launched a new variant of its WHO prequalified rotavirus vaccine Rotasiil called Rotasiil – Liquid, the…
